Journal article
Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)
Abstract
OBJECTIVE: To determine whether once-daily esomeprazole 40 mg or 20 mg compared with placebo reduces the incidence of peptic ulcers over 26 weeks of treatment in patients taking low-dose acetylsalicylic acid (ASA) and who are at risk for ulcer development.
DESIGN: Multinational, randomised, blinded, parallel-group, placebo-controlled trial.
Authors
Scheiman JM; Devereaux PJ; Herlitz J; Katelaris PH; Lanas A; van Zanten SV; Nauclér E; Svedberg L-E
Journal
Heart, Vol. 97, No. 10,
Publisher
BMJ
Publication Date
May 15, 2011
DOI
10.1136/hrt.2010.217547
ISSN
1355-6037